Bupropion for Major Depressive Disorder, Dysthymia, or Treatment-Resistant Depression

Details

Files

Project Status:

Completed

Project Line:

Reference List

Project Sub Line:

Summary of Abstracts

Project Number:

RB1558-000

1. What are the evidence-based guidelines regarding the use of bupropion in major depressive disorder, dysthymia, or treatment-resistant depression?

Four relevant evidence-based guidelines were identified regarding the use of bupropion for patients with major depressive disorder.

Last Updated : May 13, 2021